Literature DB >> 10605012

Surface expression of the IFN-gamma R2 chain is regulated by intracellular trafficking in human T lymphocytes.

L Rigamonti1, S Ariotti, G Losana, R Gradini, M A Russo, E Jouanguy, J L Casanova, G Forni, F Novelli.   

Abstract

The surface and cytoplasmic expressions of the transducing chain (IFN-gamma R2) of the heterodimeric IFN-gamma receptor on human T lymphocytes have been investigated. We show that its surface expression is low, whereas high cytoplasmic levels are found in both resting and PHA-activated T lymphocytes. This low expression does not prevent activated T cells from responding to IFN-gamma, because it induces IFN-regulatory factor 1 expression. Low surface IFN-gamma R2 expression appears to be due to recycling between cytoplasmic stores and the cell surface, which does not depend on signals mediated by endogenous IFN-gamma, because IFN-gamma R2 surface expression is low, and its internalization is equally observed in patients with inherited IFN-gamma R1 gene deficiency and in healthy donors. Moreover, IFN-gamma R2 internalization in T lymphoblasts from healthy donors was not affected by the presence of anti-IFN-gamma-neutralizing or anti-IFN-gamma R1-blocking mAb. In conclusion, these data illustrate a new mechanism whereby human T cells limit the surface expression of IFN-gamma R2 in a ligand-independent manner.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10605012     DOI: 10.4049/jimmunol.164.1.201

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

Review 1.  CTLA-4 and tolerance: the biochemical point of view.

Authors:  Shunsuke Chikuma; Jeffrey A Bluestone
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

Review 2.  Current prospects of type II interferon γ signaling and autoimmunity.

Authors:  Daniel S Green; Howard A Young; Julio C Valencia
Journal:  J Biol Chem       Date:  2017-06-26       Impact factor: 5.157

3.  The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression.

Authors:  Josiane Ragimbeau; Elisabetta Dondi; Andrés Alcover; Pierre Eid; Gilles Uzé; Sandra Pellegrini
Journal:  EMBO J       Date:  2003-02-03       Impact factor: 11.598

Review 4.  The complex and central role of interferon-γ in graft-versus-host disease and graft-versus-tumor activity.

Authors:  Hui Wang; Yong-Guang Yang
Journal:  Immunol Rev       Date:  2014-03       Impact factor: 12.988

5.  Critical role of the endogenous interferon ligand-receptors in type I and type II interferons response.

Authors:  Ahmed Lasfar; Jeffry R Cook; Karine A Cohen Solal; Kenneth Reuhl; Sergei V Kotenko; Jerome A Langer; Debra L Laskin
Journal:  Immunology       Date:  2014-07       Impact factor: 7.397

Review 6.  Interferon gamma receptor: the beginning of the journey.

Authors:  Cédric M Blouin; Christophe Lamaze
Journal:  Front Immunol       Date:  2013-09-03       Impact factor: 7.561

Review 7.  COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy.

Authors:  Carlo Perricone; Elena Bartoloni; Roberto Bursi; Giacomo Cafaro; Giacomo Maria Guidelli; Yehuda Shoenfeld; Roberto Gerli
Journal:  Immunol Res       Date:  2020-08       Impact factor: 2.829

Review 8.  The interferons and their receptors--distribution and regulation.

Authors:  Nicole A de Weerd; Thao Nguyen
Journal:  Immunol Cell Biol       Date:  2012-03-13       Impact factor: 5.126

9.  IFN-γ surmounts PD-L1/PD1 inhibition to CAR-T cell therapy by upregulating ICAM-1 on tumor cells.

Authors:  E Dong; Xiao-Zhu Yue; Lin Shui; Bin-Rui Liu; Qi-Qi Li; Yun Yang; Hui Luo; Wei Wang; Han-Shuo Yang
Journal:  Signal Transduct Target Ther       Date:  2021-01-07

10.  A method for the generation of standardized qualitative dynamical systems of regulatory networks.

Authors:  Luis Mendoza; Ioannis Xenarios
Journal:  Theor Biol Med Model       Date:  2006-03-16       Impact factor: 2.432

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.